Newer treatments for inflammatory bowel disease

Primary Care - Clinics in Office Practice

Volumn 23, Issue 3, 1996, Pages 577-608

  Stotland, B R ^a   Lichtenstein, G R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BALSALAZIDE; BECLOMETASONE; BUDESONIDE; CIPROFLOXACIN; CYCLOSPORIN A; FISH OIL; FLUTICASONE; HYDROCORTISONE; IPSALAZIDE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; OLSALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS; TIXOCORTOL; ZILEUTON;

ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; BONE MARROW SUPPRESSION; BONE NECROSIS; CARDIOTOXICITY; CORTICOSTEROID THERAPY; CROHN DISEASE; GASTROINTESTINAL TOXICITY; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE INFERTILITY; NEUROTOXICITY; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; TREATMENT PLANNING; ULCERATIVE COLITIS;

EID: 0029791156     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70349-3     Document Type: Article

References (149)

1. F. Anthonisen O. Barany O. Folkenborg The clinical effect of salazosulphapyridine (Salazopyrin) in Crohn's disease Scand J Gastro 9 1974 549 554
2. A.K. Azad Khan J. Piris S.C. Truelove An experiment to determine the active therapeutic moiety in sulphasalazine Lancet 2 1977 892 895
3. J.H. Baron A.M. Connell J.E. Lennard-Jones Sulphasalazine and salicylazosulphadimidine in ulcerative colitis Lancet 1962 1094 1096
4. G. Bianchi C. Prantera M. Campieri Comparative trial of methylprednisolone and bidesonide enema in active distal ulcerative colitis Eur J Gastro Hepatol 6 1994 125 130
5. P. Blichfeldt J.P. Blomhoff E. Myhre Metronidazole in Crohn's disease: A double blind crossover trial Scand J Gastro 13 1978 123 127
6. L.J. Brandt L.H. Bernstein S.J. Boley Metronidazole therapy for perineal Crohn's disease (A follow-up study) Gastroenterology 83 1982 383 387
7. R.I.J. Breuer S.K. Buto M.I. Christ Rectal irrigation with short chain fatty acids for distal ulcerative colitis. Preliminary report Dig Dis Sci 36 1991 185
8. C. Brignola M. Cottone A. Pera Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease Gastro 108 1995 345 349
9. M. Brogan J. Hiserodt M. Oliver The effect of 6-mercaptopurine on natural killer cell activities in Crohn's disease J Clin Immunol 5 1985 204 211
10. J. Brynskov L. Freund S.N. Rasmussen A placebo-controlled, bouble blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease N Engl J Med 321 1989 845 850
11. J. Brynskov L. Freund O.O. Thomsen Treatment of refractory ulcerative colitis with cyclosporin enemas [letter to the editor] Lancet 1 1989 721 722
12. M. Campieri P. Paoluzi G. D'albasio Better quality of therapy with 5-ASA colonic foam inactive ulcerative colitis: A multicenter comparative trial with 5-ASA enema Dig Dis Sci 38 1993 1843 1850
13. S. Candy J.P. Wright M. Gerber A double-blind controlled study of azathioprine in the treatment and maintenance of remission in Crohn's disease [abstract] Gastroenterology 106 part 2 1994 A659
14. P.A. Cann C.D. Holdsworth Systemic absorption from hydrocortisone foam enema in ulcerative colitis Lancet 1 1987 922 923
15. R. Caprilli R. Carratu M. Babbini A double-blind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis Am J Dig Dis 20 1975 115 120
16. R. Caprilli A. Andreoli G. Corrao Oral mesalazine (5-aminosalicylic acid: Asacol) for prevention of post-operative recurrence of Crohn's disease Aliment Pharm Ther 8 1994 35 43
17. N.J. Chapman M.L. Brown S.F. Phillips Distribution of mesalamine enemas in patients with active distal ulcerative colitis Mayo Clin Proc 67 1992 245 248
18. D. Clements J.E. Compston W.D. Evand Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease Gut 34 1993 1543 1546
19. C. Collawn P. Rubin N. Perez Phase II study of the safety and efficacy of a 5-lopoxygenase inhibitor in patients with ulcerative colitis Am J Gastro 87 1992 342 346
20. W.R. Connell M.A. Kamm J.K. Ritchie Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience Gut 34 1993 1081 1085
21. A. Danielsson R. Lofberg T. Persson A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis Scand J Gastro 27 1992 9 12
22. The Danish Budesonide Study Group Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with prednisolone enema as positive control Scand J Gastro 26 1991 1225 1230
23. B. Davidson P. Munkholm P. Schlichting Study of tolerability and efficacy of interferon alpha-2B treatment of Crohn's disease: A pilot study Gastro 106 1994 A670
24. P.S. Davies J. Rhodes R.V. Heatley Metronidazole in the treatment of chronic proctitis: A controlled trial Gut 18 1977 680 681
25. M.J. Dew P. Hughes A.D. Harries Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid Lancet 2 1983 801
26. A.P. Dick M.J. Grayson R.G. Carpenter Controlled trial of sulphasalazine in the treatment of ulcerative colitis Gut 5 1964 437 442
27. A.S. Dissanayake S.C. Truelove A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin) Gut 14 1973 923 926
28. K. Ewe C. Hefarth H. Malchow Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis: A multicenter trial Digestion 42 1989 224 232
29. K. Ewe A.G. Press C.C. Singe Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease Gastroenterology 105 1993 367 372
30. B. Feagan J. Rochon R.N. Fedorak Methotrexate for the treatment of Crohn's disease N Engl J Meg 332 1995 292 297
31. B.G. Feagan J.W.D. McDonald J. Rochon Low dose cyclosporine in the treatment of Crohn's disease N Engl J Med 330 1994 1846 1851
32. G.E. Feurle D. Theuer S. Velasco Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: A randomized double blind trial Gut 30 1989 1354 1361
33. R. Fiasse F. Fontaine R. Vanheuvertzwyn Prevention of Crohn's disease recurrences after intestinal resection with Eudragit-L coated 5-aminosalicylic acid. Preliminary results of a one year placebo-controlled study Gastro 100 1991 A208
34. C. Florent A. Cortot P. Quandale Placebo controlled trial of Claversal in the prevention of early endoscopic reapse after curative resection for Crohn's disease Gastro 101 1992 A623
35. H.J. Freeman W.C.P. Kwan Brief report: Non-corticosteroid associated osteonecrosis of the femoral heads in two patients with inflammatory bowel disease N Engl J Med 329 1993 1314 1316
36. J.P. Gendre J.Y. Mary C. Florent Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study Gastro 104 1993 435 439
37. T. Gilat G. Leichtman G. Delpre A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis J Clin Gastro 11 1989 393 395
38. T. Gilat A. Suisa G. Leichtman A comparison study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis J Clin Gastro 9 1987 415 417
39. P. Gionchetti M. Camperi A. Belluzzi Pentasa in maintenance treatment of ulcerative colitis Gastro 98 1990 251
40. F. Gonzalez-Huix R. de Leon F. Fernandez-Banares Entereal versus parenteral nutrition as adjunct therapy in ulcerative colitis Am J Gastro 88 1993 227 232
41. G. Greenberg B. Feagan F. Martin Oral budesonide for the treatment of active Crohn's disease N Engl J Med 331 1994 836 841
42. D.I. Grove A.A. Mahmoud K.S. Warren Suppression of cell-mediated immunity by metronidazole Arch All Appl Immun 54 1977 422 427
43. I. Hamilton I.F. Pinder R.J. Dickinson A comparison of prednisone enemas with low dose oral prednisolone in the treatment of acute distal ulcerative colitis Dis Colon Rectum 27 1984 m701
44. S.B. Hanauer F.J. Baert M. Robinson Interferon treatment in mild to moderate active Crohn's disease: Preliminary results of an open-labelled pilot study Gastro 106 1994 A696
45. S.B. Hanauer J.B. Kirsner W.E. Barrett The treatment of left-sided ulcerative colitis with tixocortol pivalate Gastro 90 1986 A1449
46. S. Hanauer E.L. Krawitt M. Robinson Long-term management of Crohn's disease with mesalamine capsules (Pentasa) Am J Gastro 88 1993 1343 1351
47. S. Hanauer B. Powers M. Robinson Maintenance of remission of ulcerative colitis by mesalamine (Asacol) vs. placebo Gastro 106 1994 A696
48. S. Hanauer J. Schwartz W. Roufail Dose-ranging study of oral mesalamine capsule (Pentasa) for active ulcerative colitis Gastro 101 1989 A195
49. J.M. Harig K.H. Woergel R.A. Komorowski Treatment of diversion colitis with short chain fatty acid irrigation N Engl J Med 320 1989 23
50. A.B. Hawthorne A. Daneshmend C.J. Hawkey Treatment of ulcerative colitis with fish oil supplementation: A prospective randomized 12-month controlled trial Gut 33 1992 922 928
51. A.B. Hawthorne R.F.A. Logan C.J. Hawkey Randomized controlled trial of azathioprine withdrawal in ulcerative colitis BMJ 305 1992 20 22
52. A.B. Hawthorne C.O. Record C.D. Holdsworth Double-blind trial of oral fluticasone proprionate versus prednisolone in the treatment of active ulcerative colitis Gut 34 1993 125 128
53. M. Hendrik Dullemen Van S.J.H. Van Deventer Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastro 109 1995 129 135
54. International mesalazine study group Coated oral 5-aminosalicylic acid versus placebo in maintaining remission in inactive Crohn's disease Aliment Pharm Ther 4 1990 55 64 428-437
55. A. Ireland C.H. Mason D.P. Jewell Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis Gut 29 1988 835 837
56. J. Jakobovits M.M. Shuster Metronidazole therapy for Crohn's disease and associated fistulae Am J Gastro 79 1984 533 540
57. D.P. Jewell S.C. Truelove Azathioprine in ulcerative colitis: Final report on controlled therapeutic trial BMJ 4 1974 627 630
58. D.P. Jewell J.E. Lennard-Jones The cyclosporine study group of Great Britain and Ireland: Oral cyclosporine for chronic active Crohn's disease: A multicenter controlled trial Eur J Gastroenterol Hepatol 6 1994 499 505
59. S. Kiilerich K. Ladefiged T. Rannem Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis Gut 33 1992 252 255
60. A.P. Kirk J.E. Lennard-Jones A controlled trial of azathioprine in chronic ulcerative colitis BMJ 284 1982 1291 1292
61. M. Klein H.J. Binder M. Mitchell Treatment of Crohn's disease with azathioprine: A controlled evaluation Gastroenterology 66 1974 916 922
62. B.I. Korelitz D.H. Present Favorable effect of 6-mercaptopurine on fistulas of Crohn's disease Dig Dis Sci 30 1985 58 64
63. B.I. Korelitz D.J. Adler R.A. Mendelsohn Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease Am J Gastroenterol 88 1993 1198 1205
64. R.A. Kozarek D.J. Patterson M.D. Gelfand Long term use of methotrexate in inflammatory bowel disease Gastro 102 1992 A648
65. R.A. Kozarek D.J. Patterson M.D. Gelfand Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease Ann Intern Med 110 1989 353
66. B.A. Lashner S.B. Hananer M.D. Silverstein Testing nicotine gum for ulcerative colitis patients Dig Dis Sci 35 1990 827
67. D.A.H. Lee M. Taylor U.T.H. James Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone 21-phosphate as a retention enema Gut 21 1980 215 218
68. M. Lemann P. Rutgeerts R. van Heuverzwijn Comparison of budesonide enema and 5-ASA enema in the treatment of active distal ulcerative colitis Hellenic J Gastro 5 1992 A776
69. J.E. Lennard-Jones Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease Dig Dis Sci 26 1981 364 368
70. J.E. Lennard-Jones Sulphasalazine in asymptomatic Crohn's disease. A multicenter trial Gut 18 1977 69 72
71. G.R. Lichtenstein Medical therapies for inflammatory bowel disease Curr Op Gastro 10 1994 390 403
72. S. Lichtiger D.H. Present Cyclosporin A in the treatment of severe ulcerative colitis [abstract] Gastroenterology 102 1992 A653
73. S. Lichtiger D.H. Present A. Kornbluth Cyclosporin in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1994 841 845
74. F.V. Linn M.A. Peppercom Drug therapy for inflammatory bowel disease Am J Surg 164 1992 85 89 178-185
75. A.J. Lobo L.D. Juby A.H. Smith Effect of oral cyclosporin on renal function in Crohn's disease Dig Dis Sci 38 1993 1624 1630
76. R. Lofberg A. Danielsson L. Salde Oral budesonide in active Crohn's disease Aliment Pharm Ther 7 1993 611 616
77. R. Lofberg O. Ostergaard-Thomsen E. Langhoz Comparative study of budesonide versus prednisolone retention enema in active distal ulcerative colitis. A Scandinavian multicenter study Aliment Pharm Ther 8 1994 623 629
78. L.R. Mackay S. Weiden B. Ungar Treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azathioprine Lancet 1 1964 899 902
79. Y.R. Mahida D.P. Jewell Slow release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease Digestion 45 1990 88 92
80. H. Malchow K. Ewe J.W. Brandes European cooperative Crohn's disease study (ECCDS): Results of drug treatment Gastro 86 1984 249 266
81. J. Markowitz K. Grancher F. Mandel Immuno-suppressive therapy in pediatric inflammatory bowel disease: Results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition Am J Gastroenterol 88 1993 44 48
82. J.W. Marsh K.L. Vehe H.M. White Immunosuppressants Gastro Clinics NA 21 1992 679 693
83. J.K. Marshall E.J. Irvine Topical aminosalicylate (ASA) therapy for distal ulcerative colitis: A meta-analysis Gastro 106 1994 A1037
84. S.G.F. Matts Intrarectal treatment of 100 cases of ulcerative colitis with prednisolone 21-phosphate retention enemata BMJ 1 1961 165 168
85. A. Matuchansky Parenteral nutrition in inflammatory bowel disease Gut 27 suppl 1 1986 81 84
86. R. McLeod B.G. Wolff H. Steinhart Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease Gastro 109 1995 404 413
87. A. Messori C. Brignola G. Trallori Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: A meta-analysis Am J Gastro 89 1994 692 698
88. S. Meyers D. Sachar J. Goldberg Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis Gastro 85 1983 351 357
89. J.J. Misiewicz J.E. Lennard-Jones A.M. Connell Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis Lancet 1965 185 189
90. C.J. Mulder G.N.J. Tytgat I.T. Weterman Double blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis Gastro 95 1988 1449 1453
91. D.P. O'Donoghue A.M. Dawson J. Powell-Tuck Double-blind withdrawal trial of Azathioprine as maintenance treatment in Crohn's disease Lancet 2 1978 955 957
92. C. O'Morain A.W. Segal A.J. Levy Elemental diets in treatment of acute Crohn's disease: A controlled trial BMJ 288 1984 1859 1862
93. M.A. Peppercorn Are antibiotics useful in the management of non-toxic severe ulcerative colitis? J Clin Gastro 17 1993 14 17
94. M.A. Peppercorn Is there a role for antibiotics as primary therapy in Crohn's ileitis? J Clin Gastro 17 1993 235 237
95. M.A. Peppercorn K. Das C. Elson Zileuton, a 5-lipoxygenase inhibitor in the treatment of active ulcerative colitis. A double-blind placebo controlled trial Gastro 106 1994 A751
96. C. Prantera A. Kohn F. Zannoni Metronidazole plus ciprofloxacin in the treatment of active refractory Crohn's disease. Results of an open study J Clin Gastro 19 1994 79 88
97. C. Prantera F. Pallone G. Brunetti Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease Gastro 103 1992 363 368
98. D.H. Present B.I. Korelitz N. Wisch Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study N Engl J Med 302 1980 981 987
99. D.H. Present S.J. Meltzer M.P. Krumholz 6-mercaptopurine in the management of inflammatory bowel disease: Short and long term toxicity Ann Intern Med 111 1989 641 649
100. R.D. Pullan J. Rhodes S. Ganesh Transdermal nicotine for active ulcerative colitis N Engl J Med 330 1994 811
101. D. Rachmilewitz Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial BMJ 298 1989 82 86
102. T. Ranzi M.C. Campanini P. Velio Treatment of chronic proctosigmoiditis with cyclosporin enemas [letter to the editor] Lancet 2 1989 97
103. S.S.C. Rao S.A.C. Dundas C.D. Holdsworth Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study Gut 30 1989 675 679
104. S.N. Rasmussen K. Lauritsen U. Tage-Jensen 5-Aminosalicylic acid in the treatment of Crohn's disease Scad J Gastro 22 1987 877 883
105. J.C. Reynolds D.R. Trellis Abu-Elmagd The rational for FK506 in inflammatory bowel disease Can J Gastro 7 1993 208
106. J. Rhodes D. Bainton P. Beck Controlled trial of Azathioprine in Crohn's disease Lancet 2 1971 1272 1276
107. S. Ricca Rosellini D. Valpiani M. Spada 5-Aminosalicylic acid and sulphasalazine in acute and maintenance treatment of ulcerative colitis. A meta-analysis of comparative randomized trials Gastro 100 1991 A243
108. M.C.M. Rijk H.J.J. van Lier van Tongeren Relapse-preventing effect and safety of sulphasalazine and olsalazine in patients with ulcerative colitis in remission: A prospective, double-blind, randomized multicenter study Am J Gastro 87 1992 438 442
109. S.A. Riley V. Mani M.J. Goodman Comparison of delayed release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis Gastro 94 1988 1383 1389
110. S.A. Riley V. Mani M.J. Goodman Comparison of delayed release 5-aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse Gut 29 1988 669 674
111. J.L. Rosenberg B. Levin A.J. Wall A controlled trial of Azathioprine in Crohn's disease Dig Dis 20 1975 721 726
112. J.L. Rosenberg A.J. Wall B. Levin A controlled trial of azathioprine in the management of chronic ulcerative colitis Gastroenterology 69 1975 96 99
113. P. Rutgeerts M. Hiele K. Geboes Controlled trial of metronidazole for prevention of Crohn's recurrence after ileal resection Gastro 1908 1995 1617 1621
114. P. Rutgeerts R. Lofberg H. Malchow A comparison of budesonide with prednisolone for active Crohn's disease N Engl J Med 331 1994 842 845
115. P. Rutgeerts M. Peeters M. Hiele A placebo-controlled trial of metronidazole for recurrence prevention of Crohn's disease after resection of the terminal ileum Gastro 102 1992 A688
116. W.J. Sandborn Clinical review: A critical review of cyclosporine therapy in inflammatory bowel disease Inflamm Bowel Diseases 1 1995 48 63
117. W.J. Sandborn E.C. An Os B.J. Zins An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease Gastro 109 1995 1808 1817
118. W.J. Sandborn W.J. Tremaine K.W. Schroeder Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis Am J Gastroenterol 88 1993 640 645
119. W.J. Sandborn W.J. Tremaine K.W. Schroeder A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis Gastroenterology 106 1994 1429 1435
120. L.W. Scheppach H. Summer T. Kirchner Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis Gastro 103 1992 51
121. K.W. Schroeder W.J. Tremaine D.M. Ilstrup Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis N Engl J Med 317 1987 1625 1629
122. D.B.A. Silk Payne-James Inflammatory bowel disease. Nutritional implications and treatment Proc Nutr Soc 48 1989 355 361
123. J.W. Singleton S.B. Hanauer G.L. Gitnick Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial Gastro 104 1993 1293 1301
124. C.A. Sninsky D.H. Cort F. Shanahan Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis Ann Intern Med 115 1991 350 355
125. J.A. Spencer J.B. Kirsner Experience with short and long-term courses of local adrenal steroid therapy for ulcerative colitis Gastro 6 1962 66 67
126. M.J. Spirt Antibiotics in inflammatory bowel disease. New choices for an old disease Am J Gastro 89 1994 974
127. Stange EF, Modigliani R, Penna S, et al: European trial of Sandimmune in Crohn's disease (ETSCD): Results [Abstract]. Falk Symposium 72, IV International Symposium on Inflammatory Bowel Diseases, Strasbourg, France, 1993
128. A.H. Steinhart D. Hemphill G.R. Greenberg Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: A meta-analysis Am J Gastro 89 1994 2116 2124
129. R.W. Summers D.M. Switz J.T. Sessions National Cooperative Chn's Disease Study: Results of drug treatment Gastroenterology 77 1979 847 869
130. L.R. Sutherland G.R. May E.A. Shaffer Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis Ann Intern Med 118 1993 540 549
131. L.R. Sutherland J. Singleton J. Sessions Double blind, placebo controlled trial of metronidazole in Crohn's disease Gut 32 1991 1071 1075
132. N. Svartz Salazopyrin, a new sulfanilamide preparation: A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations in treatment with sulfanilamide preparation Acta Med Scand 110 1942 557 590
133. S. Tarpila U. Turunen K. Seppala Budesonide enema in active haemorrhagic proctitis—A controlled trial against hydrocortisone foam enema Aliment Pharmacol Ther 8 1994 591 595
134. K. Teahon I. Bjarnason M. Pearson Ten years' experience with an elemental diet in the management of Crohn's disease Gut 31 1990 1133 1137
135. W.J. Tremaine W.J. Sandborn S.F. Phillips Short chain fatty acid enema therapy for treatment resistant pancolitis following ileal-pouch anal anastomisis Gastro 106 1994 A784
136. S.C. Truelove Treatment of ulcerative colitis with local hydrocortisone BMJ 2 1956 1267 1272
137. S.C. Truelove Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium: A report on a controlled therapeutic trial BMJ 2 1958 1072 1077
138. U. Turunen Farkkila K. Hakala A double-blind placebo controlled six month ciprofloxacin treatment improves prognosis in ulcerative colitis Gastro 106 1994 A786
139. U. Turunen M. Farkkila V. Valtonen Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn's disease Gastro 104 1993 A793
140. B. Ursing C. Kamme Metronidazole for Crohn's disease Lancet 1 1975 775 777
141. H.M. Van Dullemen S.J.H. Van Deventer D.W. Hommes Treatment of Crohn's disease with anti-tumor necrosis factor chimeris antibody (cA2) Gastro 109 1995 129 135
142. P.A.M. Van Hees H.J.J. Van Lier P.H. Van Elteren Effect of sulphasalazine in patients with active Crohn's disease: A controlled double-blind study Gut 22 1981 404 409
143. A. Wenkert M. Kristensen E.R.E. Eklund The long-term prophylactic effect of salazosulphapyridine (salazopyrin) in primarily resected patients with Crohn's disease: A controlled double-blind trial Scand J Gastroenterol 13 1978 161 167
144. C.P. Willoughby R.E. Cowan S.R. Gould Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis Scand J Gastro 23 suppl 148 1988 4 44
145. J.M. Willoughby J. Beckett P.J. Kumar Controlled trial of Azathioprine in Crohn's disease Lancet 2 1971 944 947
146. T.A. Winter H.R. Dlaton M.N. Merrett Cyclosporin A retention enemas in refractory distal ulcerative colitis and `pouchitis,' Scand J Gastroenterol 28 1993 701 704
147. J.P. Wright S. Jarnum O.S. Muckadell Oral fluticasone proprionate compared with prednisolone in treatment of active Crohn's disease: A randomized double-blind multicenter study Eur J Gastro Hepatol 5 1993 499 503
148. J. Zinberg S. Molinas K.M. Das Double-blind placebo-controlled study of olsalazine in the treatment of ulcerative colitis Am J Gastro 85 1990 562 566
149. A.R. Zinsmeister A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis Gastroenterology 106 1994 1429 1435